日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CAR-adapted PIK3CD base editing enhances T cell anti-tumor potency.

CAR 改造的 PIK3CD 碱基编辑增强了 T 细胞的抗肿瘤效力。

Bucher Philip, Brückner Nadine, Kortendieck Jule, Grimm Melanie, Schleicher Jan T, Bartels Karlotta, Hardy Steffen, Rausch Martina, Wurzer Hannah, Thiemann Meike, May Celina, Mitstorfer Mara, Letzgus Dennis, Quach Julia, Schneider Carolin, Ispan Denis A, Gonzalez-Menendez Irene, Jain Nayan, Ho Yu-Jui, Chen Jiangqing, Sánchez-Rivera Francisco J, Sun Jie, Quintanilla-Martinez Leticia, Trautwein Christoph, Weigelin Bettina, Claassen Manfred, Sadelain Michel, Feucht Judith, Leibold Josef

Anti-uPAR CAR T cells reverse and prevent aging-associated defects in intestinal regeneration and fitness.

抗 uPAR CAR T 细胞可逆转和预防与衰老相关的肠道再生和功能缺陷。

Eskiocak Onur, Gewolb Joseph, Shah Vyom, Rouse James A, Chowdhury Saria, Akyildiz Erdogan O, Fernández-Maestre Inés, Boyer Jacob A, Filliol Aveline, Harris Alexander S, Utama Raditya, Guo Guangran, Castro-Hernández Carolina, Nnuji-John Emmanuella, Chung Charlie, Anderson Arianna, Flowers Sara, Habel Jill, Romesser Paul B, Levine Ross L, Lowe Scott W, Sadelain Michel, Beyaz Semir, Amor Corina

CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53

CD4+ T 细胞淋巴瘤携带嵌合抗原受体整合于 TP53

Perica, Karlo; Jain, Nayan; Scordo, Michael; Patel, Ruchi; Eren, Ozgur Can; Patel, Utsav; Gundem, Gunes; Domenico, Dylan; Mitra, Sneha; Socci, Nicholas D; Everett, John K; Roche, Aoife M; Petrichenko, Angelina; Shah, Gunjan L; Arcila, Maria E; Borsu, Laetitia; Park, Jae H; Horwitz, Steven M; Giralt, Sergio A; Dogan, Ahmet; Leslie, Christina; Papaemmanuil, Elli; Bushman, Frederic D; Usmani, Saad Z; Sadelain, Michel; Mailankody, Sham

Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma

一项针对新型CD19-1XX嵌合抗原受体的I期临床试验结果显示,该受体在大B细胞淋巴瘤中具有可校准的信号传导功能。

Park, Jae H; Palomba, M Lia; Perica, Karlo; Devlin, Sean M; Shah, Gunjan; Dahi, Parastoo B; Lin, Richard J; Salles, Gilles; Scordo, Michael; Nath, Karthik; Valtis, Yannis K; Lynch, Alec; Cathcart, Elizabeth; Zhang, Honglei; Schoder, Heiko; Leithner, Doris; Liotta, Kelly; Yu, Alina; Stocker, Kelsey; Li, Jia; Dey, Agnish; Sellner, Leopold; Singh, Reshma; Sundaresan, Varsha; Tong, Xin; Zhao, Faye; Mansilla-Soto, Jorge; He, Changhao; Meyerson, Joel; Hosszu, Kinga; McAvoy, Devin; Wang, Xiuyan; Rivière, Isabelle; Sadelain, Michel

Zelig Eshhar (1941–2025): a tribute for a life for immunotherapy

泽利格·埃沙尔(1941–2025):致敬其为免疫疗法做出的毕生贡献

Shrimali, Rajeev; Ahmad, Shamim; Berrong, Zuzana; Okoev, Grigori; Matevosyan, Adelaida; Razavi, Ghazaleh Shoja E; Petit, Robert; Gupta, Seema; Mkrtichyan, Mikayel; Khleif, Samir N; Abken, Hinrich; Allison, James P; Brentjens, Renier; June, Carl H; Lotze, Michael T; Mackall, Crystal; Majzner, Robbie G; Rosenberg, Steven A; Sadelain, Michel; Smith, Eric; Maus, Marcela V

Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies

用于治疗复发或难治性B细胞恶性肿瘤的同种异体现成CAR-T细胞疗法

Shahid, Sanam; Prockop, Susan E; Flynn, Georgia C; Mauguen, Audrey; White, Charlie O; Bieler, Jennifer; McAvoy, Devin; Hosszu, Kinga; Cancio, Maria I; Jakubowski, Ann A; Scaradavou, Andromachi; Boelens, Jaap Jan; Sauter, Craig S; Perales, Miguel-Angel; Giralt, Sergio A; Taylor, Clare; Chaudhari, Jagrutiben; Wang, Xiuyan; Rivière, Isabelle; Sadelain, Michel; Brentjens, Renier J; Kernan, Nancy A; O'Reilly, Richard J; Curran, Kevin J

Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective

推进嵌合抗原受体(CAR)T细胞疗法治疗系统性红斑狼疮(SLE)的关键考量:多方合作/学科工作组的视角

Hsieh, Elena W Y; Chung, James B; Amin, Afsah; Askanase, Anca D; Bartok, Beatrix; Brunetta, Paul; Carrasco-Alfonso, Marlene J; Coney, Cindy; Cooper, Jennifer C; Dall'Era, Maria; Delev, Nikolay; Eldred, Ann; Furie, Richard A; Garces, Sandra; Groover, Katie; Harrington, Monica; Hogan, Jonathan J; Imperato, Gavin H; Jackson, Meredith; Jackson, Shaun W; Jongco, Artemio M; Karis, Elaine; Koegel, Ashley; König, Maximilian F; Koretzky, Gary; Kumar, Vijay; Morand, Eric; Payne, Aimee S; Popat, Vaishali; Rizvi, Naiyer; Rohan, Patricia; Sadelain, Michel; Schett, Georg; Singh, Aman P; van Vollenhoven, Ronald F; Zack, Debra

CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results

CD19 CAR T 细胞疗法联合预防性使用阿那白滞素治疗复发或难治性淋巴瘤:II 期临床试验中期结果

Park, Jae H; Nath, Karthik; Devlin, Sean M; Sauter, Craig S; Palomba, M Lia; Shah, Gunjan; Dahi, Parastoo; Lin, Richard J; Scordo, Michael; Perales, Miguel-Angel; Shouval, Roni; Tomas, Ana Alarcon; Cathcart, Elizabeth; Mead, Elena; Santomasso, Bianca; Holodny, Andrei; Brentjens, Renier J; Riviere, Isabelle; Sadelain, Michel

Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

作者更正:抗CD19 CAR T细胞疗法后肠道微生物群与疗效和毒性的相关性

Smith, Melody; Dai, Anqi; Ghilardi, Guido; Amelsberg, Kimberly V; Devlin, Sean M; Pajarillo, Raymone; Slingerland, John B; Beghi, Silvia; Herrera, Pamela S; Giardina, Paul; Clurman, Annelie; Dwomoh, Emmanuel; Armijo, Gabriel; Gomes, Antonio L C; Littmann, Eric R; Schluter, Jonas; Fontana, Emily; Taur, Ying; Park, Jae H; Palomba, Maria Lia; Halton, Elizabeth; Ruiz, Josel; Jain, Tania; Pennisi, Martina; Afuye, Aishat Olaide; Perales, Miguel-Angel; Freyer, Craig W; Garfall, Alfred; Gier, Shannon; Nasta, Sunita; Landsburg, Daniel; Gerson, James; Svoboda, Jakub; Cross, Justin; Chong, Elise A; Giralt, Sergio; Gill, Saar I; Riviere, Isabelle; Porter, David L; Schuster, Stephen J; Sadelain, Michel; Frey, Noelle; Brentjens, Renier J; June, Carl H; Pamer, Eric G; Peled, Jonathan U; Facciabene, Andrea; van den Brink, Marcel R M; Ruella, Marco

Programming CAR T Cell Tumor Recognition: Tuned Antigen Sensing and Logic Gating

CAR-T细胞肿瘤识别编程:调控抗原感知和逻辑门控

Hamieh, Mohamad; Mansilla-Soto, Jorge; Rivière, Isabelle; Sadelain, Michel